IMPECCABLE: Integrated Modeling PipelinE for COVID Cure by Assessing Better LEads
Authors:
Aymen Al Saadi,
Dario Alfe,
Yadu Babuji,
Agastya Bhati,
Ben Blaiszik,
Thomas Brettin,
Kyle Chard,
Ryan Chard,
Peter Coveney,
Anda Trifan,
Alex Brace,
Austin Clyde,
Ian Foster,
Tom Gibbs,
Shantenu Jha,
Kristopher Keipert,
Thorsten Kurth,
Dieter Kranzlmüller,
Hyungro Lee,
Zhuozhao Li,
Heng Ma,
Andre Merzky,
Gerald Mathias,
Alexander Partin,
Junqi Yin
, et al. (11 additional authors not shown)
Abstract:
The drug discovery process currently employed in the pharmaceutical industry typically requires about 10 years and $2-3 billion to deliver one new drug. This is both too expensive and too slow, especially in emergencies like the COVID-19 pandemic. In silicomethodologies need to be improved to better select lead compounds that can proceed to later stages of the drug discovery protocol accelerating…
▽ More
The drug discovery process currently employed in the pharmaceutical industry typically requires about 10 years and $2-3 billion to deliver one new drug. This is both too expensive and too slow, especially in emergencies like the COVID-19 pandemic. In silicomethodologies need to be improved to better select lead compounds that can proceed to later stages of the drug discovery protocol accelerating the entire process. No single methodological approach can achieve the necessary accuracy with required efficiency. Here we describe multiple algorithmic innovations to overcome this fundamental limitation, development and deployment of computational infrastructure at scale integrates multiple artificial intelligence and simulation-based approaches. Three measures of performance are:(i) throughput, the number of ligands per unit time; (ii) scientific performance, the number of effective ligands sampled per unit time and (iii) peak performance, in flop/s. The capabilities outlined here have been used in production for several months as the workhorse of the computational infrastructure to support the capabilities of the US-DOE National Virtual Biotechnology Laboratory in combination with resources from the EU Centre of Excellence in Computational Biomedicine.
△ Less
Submitted 13 October, 2020;
originally announced October 2020.
The effect of population abundances on the stability of large random ecosystems
Authors:
Theo Gibbs,
Jacopo Grilli,
Tim Rogers,
Stefano Allesina
Abstract:
Random matrix theory successfully connects the structure of interactions of large ecological communities to their ability to respond to perturbations. One of the most debated aspects of this approach is the missing role of population abundances. Despite being one of the most studied patterns in ecology, and one of the most empirically accessible quantities, population abundances are always neglect…
▽ More
Random matrix theory successfully connects the structure of interactions of large ecological communities to their ability to respond to perturbations. One of the most debated aspects of this approach is the missing role of population abundances. Despite being one of the most studied patterns in ecology, and one of the most empirically accessible quantities, population abundances are always neglected in random matrix approaches and their role in determining stability is still not understood. Here, we tackle this question by explicitly including population abundances in a random matrix framework. We obtain an analytical formula that describes the spectrum of a large community matrix for arbitrary feasible species abundance distributions. The emerging picture is remarkably simple: while population abundances affect the rate to return to equilibrium after a perturbation, the stability of large ecosystems is uniquely determined by the interaction matrix. We confirm this result by showing that the likelihood of having a feasible and unstable solution in the Lotka-Volterra system of equations decreases exponentially with the number of species for stable interaction matrices.
△ Less
Submitted 29 August, 2017;
originally announced August 2017.
